This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Highlights include: Due to the aging population and improvement in diagnostic strategies, the prevalence of heartvalve disease is expected to double by 2040 and triple by 2060.As As a result, it is estimated that the number of patients requiring heartvalve interventions will increase significantly in the coming decades.
I’m also excited to work closely with my peers on the JACC editorial team as we help shape contemporary research priorities, and as such, propel improvements in clinical care to ultimately improve patient outcomes.” She also will lead and assess content initiatives, manuscript assignment and peer-review processes.
IntroductionEnhanced Recovery After Surgery (ERAS) protocols represent a paradigm shift in perioperative care, aim to optimize patient outcomes and accelerate recovery. These findings have broad implications for improving patientcare outcomes and advancing perioperative practices in cardiac surgery settings.
Last week marked a significant milestone as the center of excellence for Transcatheter Aortic Valve Implantation (TAVI) procedures hosted a highly successful TAVI Masterclass. Dr. Ibrahim Halil Kurt, renowned for his pioneering contributions to heartvalve disease, the event featured live demonstrations of five intricate TAVI cases.
With the integration of FEops, the Mimics Planner will offer a comprehensive solution for anatomy-based 3D planning and AI-based simulation, allowing clinicians to simulate the interaction between a medical device, such as a heartvalve, and a patient’s unique anatomy. For more information, please visit www.materialise.com.
Last week marked a significant milestone as the center of excellence for Transcatheter Aortic Valve Implantation (TAVI) procedures hosted a highly successful TAVI Masterclass. Dr. Ibrahim Halil Kurt, renowned for his pioneering contributions to heartvalve disease, the event featured live demonstrations of five intricate TAVI cases.
Their testimony encapsulates the essence of our programs - an immersive, dedicated training encompassing advanced heartvalve interventions without invasive procedures. It's a testament to our dedication to equipping medical professionals with the skills and knowledge required to advance patientcare.
Their testimony encapsulates the essence of our programs - an immersive, dedicated training encompassing advanced heartvalve interventions without invasive procedures. It's a testament to our dedication to equipping medical professionals with the skills and knowledge required to advance patientcare.
Image courtesy of UC Davis Health milla1cf Tue, 04/09/2024 - 16:47 April 9, 2024 — UC Davis Health cardiology team members are among the first in the country to treat patients with tricuspid regurgitation , or a leaky heartvalve, by using a groundbreaking catheter.
mtaschetta-millane Mon, 07/29/2024 - 09:02 July 29, 2024 — Edwards Lifesciences announced investments that reflect the company’s deep commitment to advancing patientcare through structural heart innovation, addressing large unmet patient needs and supporting sustainable long-term growth.
Barr’s death at 39 from sudden cardiac arrest was caused by mitral valve prolapse—a heartvalve defect that can affect the heart’s ability to pump blood. This individualized approach is unique. What excites you about the future of heartvalve disease study? It can, in some cases, lead to death.
Additionally, the company also offers the first fully automated 3D quantification of mitral regurgitation (MR) volumes* designed to provide reproducible, efficient analysis helps clinicians make better-informed decisions for patients with heartvalve disease. “As
Their teamwork and collaboration, allows us to advance collective efforts within this sector, driving forward innovation and enhancing patientcare," said SCAI Interventional Cardiology Program Chair, J.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content